关于华法林在当前时代的作用的批判性评估
1Head, Department of Cardiology & Interventional Cardiology, PRS Hospital, Trivandrum, Kerala, India, Corresponding Author.
概括
华法林仍然是一个重要的口服抗凝剂 (OAC),尽管新的选择. 有效的管理,特别是INR监测,对于直接口服抗凝剂 (DOACs) 不适合的患者至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 60多年来,华法林一直是口服抗凝剂 (OAC) 的基石.
- 已确定的疗效,安全性和逆转方法使其成为常规药物.
- 新型/直接OACs (DOACs) 已经出现,但华法林仍然具有相关性.
研究的目的:
- 批判性地评估华法林在当前抗凝剂领域的作用.
- 审查优化华法林治疗和患者坚持治疗的战略.
- 为了突出华法林在特定患者群体中的持续重要性.
主要方法:
- 审查关于华法林和DOACs的现有文献.
- 与DOAC相比,华法林的益处和局限性的分析.
- 讨论华法林管理的挑战和解决方案,特别是INR监测.
主要成果:
- 华法林仍然是75岁以上的患者,患有功能衰竭 (CrCl <30毫升/分钟) 和机械假体置换的患者的首选药物.
- 对于某些患者群体来说,DOACs可能是禁忌的,耐受性较差,或无法负担.
- 精确的国际规范化比率 (INR) 管理对于华法林疗效至关重要.
结论:
- 华法林仍然是特定患者子组的关键OAC.
- 护理地点的INR监测和抗凝疗诊所可以改善华法林治疗结果.
- 优化治疗控制和患者坚持治疗是最大限度地提高华法林益处的关键.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
686
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521
Therapeutic Index
4.2K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.2K
Pharmacovigilance
826
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
826
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K


